Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biomark Diagnostics Inc (BUX.CN)

Biomark Diagnostics Inc (BUX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biomark Diagnostics Inc 130 - 3851 Shell Road Richmond BC V6X 2W2 CAN

https://www.biomarkdiagnostics.com P: 604-836-6950

Sector:

N/A

Description:

Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the early-stage cancer diagnostic technology platform. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early cancer treatment. Its research and development are focused on the role that metabolomics plays in early cancer detection. The company's objective is to commercialize its inventive technology. and strive to increase the predictive accuracy in early-stage cancer detection.

Key Statistics

Overview:

Market Capitalization, $K 57,800
Shares Outstanding, K 105,090
% of Institutional Shareholders 63.07%

Financials:

Annual Sales, $ 154 K
Annual Net Income, $ -1,927 K
Last Quarter Sales, $ 7 K
Last Quarter Net Income, $ -481 K

Growth:

1-Year Return 139.13%
3-Year Return 168.29%
5-Year Return 266.67%
5-Year Revenue Growth -10.15%
5-Year Earnings Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.01 on 11/28/25
Next Earnings Date N/A
Earnings Per Share ttm -0.01
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -20.00%
Dividend Payout Ratio 0.00%

BUX.CN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % -120.06%
Profit Margin % -1,249.73%
Debt/Equity 0.09
Price/Sales 436.85
Price/Book 66.94
Book Value/Share 0.01
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar